Hematopoietic stem cell transplantation: a global perspective.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2010-04-28

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1001/jama.2010.491PMID 20424252PMCID PMC3219875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report

  2009cited by this paper
• Stem-cell experts raise concerns about medical tourism.

  2009cited by this paper
• Call for global health-systems impact assessments.

  2009cited by this paper
• Allogeneic hematopoietic SCT for patients with autoimmune diseases

  2009cited by this paper
• Risk score for outcome after allogeneic hematopoietic stem cell transplantation

  2009cited by this paper
• Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.

  2009cited by this paper
• The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research

  2008cited by this paper
• The organ donor crisis: the missed organ donor potential from the accident and emergency departments.

  2008cited by this paper
• What is the impact of hematopoietic cell transplantation (HCT) for older adults with acute myeloid leukemia (AML)?

  2008cited by this paper
• Stem cell therapy in myocardial repair and remodeling.

  2008cited by this paper
• Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.

  2008cited by this paper
• The Japan Marrow Donor Program, the Japan Cord Blood Bank Network and the Asia Blood and Marrow Transplant Registry

  2008cited by this paper
• Cell therapy for ischaemic heart disease

  2008cited by this paper
• Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

  2008cited by this paper
• The changing face of neural stem cell therapy in neurologic diseases.

  2008cited by this paper
• Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe—Impact of cost considerations

  2007cited by this paper
• Stem cell transplantation in Europe: trends and prospects.

  2007cited by this paper
• Hematopoietic-cell transplantation at 50.

  2007cited by this paper
• Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

  2007cited by this paper
• Do affluent societies have the only options for the best therapy?

  2007cited by this paper
• From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells

  2007cited by this paper
• Uses and Growth of Hematopoietic Cell Transplantation

  2007cited by this paper
• Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004.

  2007cited by this paper
• Predictability of hematopoietic stem cell transplantation rates

  2007cited by this paper
• Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors

  2006cited by this paper
• Hematopoietic stem-cell transplantation.

  2006cited by this paper
• Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE

  2006cited by this paper
• Hematopoietic stem-cell transplantation.

  2006cited by this paper
• Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.

  2006cited by this paper
• Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe

  2002cited by this paper
• Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

  2002cited by this paper
• Bone marrow transplantation activity in Europe 1992: report from the European Group for Bone Marrow Transplantation (EBMT).

  1994cited by this paper
• Bone marrow transplantation activity in Europe 1990. European Group for Bone Marrow Transplantation (EBMT)

  1991cited by this paper
• The Acquisition of Data

  1969cited by this paper

• Pathways of Resistance: Modern Multiple Myeloma Therapies and Overcoming Reliance on Genomic Integrity

  2026cites this paper
• Bruton’s Tyrosine Kinase Inhibitors and Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: A Review of Complementary Paradigms for a Divergent Disease

  2026cites this paper
• Pediatric hematopoietic stem cell transplant program in resource-constrained setting: overcoming the challenges

  2025cites this paper
• Interleukin-17 and transplant immunology: clinical evidence from hematopoietic cell transplantation

  2025cites this paper
• The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT

  2025cites this paper
• Fertility assessment in long-term young female survivors with hematological disease after allogeneic hematopoietic cell transplantation: a single-center real-life cross-sectional study

  2025cites this paper
• Urine Cell-Free RNA vs Plasma Cell-Free RNA for Monitoring of Kidney Injury and Immune Complications

  2025cites this paper
• Multisite Randomized Trial of Inpatient Palliative Care Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation.

  2025cites this paper
• Establishing disease-specific thresholds for automated hematopoietic progenitor cell counting in hematological malignancies

  2025cites this paper
• Optimizing anti-thymocyte globulin dosing in allogeneic hematopoietic stem cell transplantation: individualized approaches and clinical implications

  2025cites this paper
• Simplification of Hematopoietic Stem Cell Transplantation and Continued FACT Accreditation: Strategies for Low- and Middle-Income Countries.

  2025cites this paper
• Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors

  2025cites this paper
• Exploring the financial burden of pediatric bone marrow transplantation: a cross-sectional Study from the caregiver’s viewpoint

  2025cites this paper
• Assessing the visibility and public engagement of bone marrow and stem cell transplantation research: An altmetric analysis

  2025cites this paper
• Differences in the incidence and mortality of tracheal, bronchus, and lung cancer between the Global Cancer Observatory 2022 and the Global Burden of Disease 2021

  2025cites this paper
• A Digital Intervention to Address Sexual Health in Hematopoietic Stem Cell Transplant Survivors.

  2025cites this paper
• The Changing Landscape of Opportunity for Cure of Severe Hemoglobinopathies in Middle-Income Regions

  2025cites this paper
• Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG‐PTCy‐CSA for GVHD prophylaxis

  2025cites this paper
• Safety and efficacy of leriglitazone in childhood cerebral adrenoleukodystrophy (NEXUS): an interim analysis of an open-label, phase 2/3 trial

  2025cites this paper
• Graft Rejection After Ex Vivo T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation: Analysis of Incidence, Survival, Risk Factors, and Association With Biomarkers of Inflammation.

  2025cites this paper
• Advancing Hematopoietic Stem Cell Transplantation (HSCT) in Africa: A Pathway to Curing Hematological Disorders

  2025cites this paper
• 30 años de experiencia en trasplante de células hematopoyéticas en el Centro de Hematología y Medicina Interna de la Clínica Ruiz de Puebla

  2025cites this paper
• The Lived Experience of Adult Cancer Survivors After Hematopoietic Stem Cell Transplantation: A Qualitative Study From Saudi Arabia

  2025cites this paper
• Profoundly Depleted: Qualitative Study of Persistent Fatigue Following Hematopoietic Cell Transplant.

  2025cites this paper
• Recent advancements in hematopoietic stem cell transplantation in Taiwan

  2024cites this paper
• Pulmonary Immunocompromise in Stem Cell Transplantation and Cellular Therapy.

  2024cites this paper
• 人类疱疹病毒感染在造血干细胞移植后难治性肠道移植物抗宿主病中的作用及诊断和治疗

  2024cites this paper
• Pós transplante de células tronco hematopoiética: análise de custos das infecções no primeiro ano de transplante

  2024cites this paper
• Outcome of pulmonary complications after hematopoietic stem cell transplantation

  2024cites this paper
• The role of registries in hematological disorders.

  2024cites this paper
• Risk factors and predictive model for mortality in patients undergoing allogeneic hematopoietic stem cell transplantation admitted to the intensive care unit

  2024cites this paper
• Protocol for multi-site randomized trial of inpatient palliative care for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation.

  2024cites this paper
• A novel psychosocial virtual reality intervention (BMT-VR) for patients undergoing hematopoietic stem cell transplantation: Pilot randomized clinical trial design and methods.

  2024cites this paper
• Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experience

  2024cites this paper
• Photobiomodulation minimizes taste changes during hematopoietic cell transplantation: A randomized clinical trial

  2024cites this paper
• A Positive Psychology Intervention in Allogeneic Hematopoietic Stem Cell Transplantation Survivors (PATH): A Pilot Randomized Clinical Trial.

  2024cites this paper
• Design and Development of a Multimodal Digital Intervention (SHIFT App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant (HSCT) Survivors.

  2024cites this paper
• NFAT5 counters long-term IFN-1 responses in hematopoietic stem cells to preserve reconstitution potential

  2024cites this paper
• Analyze the Performance of Bone Marrow Transplantation (Adults) using Machine Learning Algorithms

  2024cites this paper
• Oral malignant and potentially malignant lesions after allogenic hematopoietic cell transplantation: a 10-year follow-up study

  2024cites this paper
• Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMT

  2024cites this paper
• Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease

  2024cites this paper
• Prediction of Viable CD34 Count in Harvested Product by Peripheral Blood Hematopoietic Progenitor Count of Automated Hematology Analyzer Undergoing Hematopoietic Stem Cell Transplantation

  2024cites this paper
• The transplantation effect of pegylated granulocyte colony-stimulating factor mobilized hematopoietic stem cells may be superior to that of G-CSF mobilized hematopoietic stem cells in haploidentical allogeneic hematopoietic cell transplantation.

  2024cites this paper
• Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT

  2024cites this paper
• Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors

  2024cites this paper
• 慢性移植物抗宿主病患者生活质量评估及其差异研究

  2024cites this paper
• Application of the National Comprehensive Cancer Network-distress thermometer in pediatric patients during autologous and allogeneic hematopoietic stem cell transplantation and relationship to blood parameters of the stress axis

  2023cites this paper
• A successfully cured case of cytomegalovirus multiple organ infection after hematopoietic stem cell transplantation: A case report

  2023cites this paper
• Mobile Technology to Monitor and Support Health and Well-Being: Qualitative Study of Perspectives and Design Suggestions From Patients Undergoing Hematopoietic Cell Transplantation

  2023cites this paper
• Temporal trends in hematopoietic stem cell transplantation in Argentina between 2009 and 2018: A collaborative study by GATMO-TC and INCUCAI TaggedEnd

  2023cites this paper
• Epidemiology, treatment patterns, and disease burden of cytomegalovirus in hematopoietic cell transplant recipients in selected countries outside of Europe and North America: A systematic review

  2023cites this paper
• Panhematopoietic RNA barcoding enables kinetic measurements of nucleate and anucleate lineages and the activation of myeloid clones following acute platelet depletion

  2023cites this paper
• Inflammatory Cytokines and Depression Symptoms Following Hematopoietic Cell Transplantation.

  2023cites this paper
• Temporal trends in hematopoietic stem cell transplantation in Argentina between 2009 and 2018: A collaborative study by GATMO-TC and INCUCAI TaggedEnd

  2023cites this paper
• Ikaros expression is associated with an increased risk of chronic graft-versus-host disease

  2023cites this paper
• Gastrointestinal Biopsies in the Patient Post-Stem Cell Transplant: An Approach to Diagnosis.

  2023cites this paper
• System dynamics analysis of mortality post allogeneic hematopoietic stem cell transplant

  2023cites this paper
• Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey

  2023cites this paper
• Molecular disparity of HLA‐DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation

  2023cites this paper
• A Novel Scientometrics Research on the Interaction between Oxidative Stress and Hematopoietic Stem Cell Transplantation Complications: From Graft-versus-Host Disease to Sepsis

  2023cites this paper
• Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease

  2023cites this paper
• Adoptive immune transfer from donors offers Anti-HBV protection to HBsAb-negative patients after Allo-HSCT

  2023cites this paper
• Adult T-cell leukemia and lymphoma in French Guiana: a retrospective analysis with real-life data from 2009 to 2019

  2023cites this paper
• A nomogram model for predicting ocular GVHD following allo-HSCT based on risk factors

  2023cites this paper
• Hematopoietic cell transplants in resource-poor countries: challenges and opportunities

  2023cites this paper
• American Society of Transplantation and Cellular Therapy International Affair Committee: Report of 3rd Workshop on Global Perspective to Access to Transplantation at the 2022 Tandem Meeting.

  2023cites this paper
• The Proportion of Myeloid-derived Suppressor Cells in the Graft as a Potential Predictor of Acute Graft-versus-host Disease in Haploid Allogeneic Hematopoietic Stem Cell Transplantation

  2023cites this paper
• Microfabrication of Gelatin Methacrylate/Hydroxyapatite Composites by Utilizing Alternate Soaking Process

  2023cites this paper
• Gifts, wine and blood

  2023cites this paper
• A longitudinal multidimensional rehabilitation program for patients undergoing allogeneic blood and marrow transplantation (CaRE-4-alloBMT): Protocol for a phase II feasibility pilot randomized controlled trial

  2023cites this paper
• Protection of haematopoietic progenitor cell donors: an updated overview of the European landscape

  2023cites this paper
• Male fertility preservation and restoration strategies for patients undergoing gonadotoxic therapies

  2022cites this paper
• Temporal trends in hematopoietic stem cell transplantation in Argentina between 2009 and 2018: A collaborative study by GATMO-TC and INCUCAI

  2022cites this paper
• External Validation of the Revised Pretransplant Assessment of Mortality Score in Allogeneic Hematopoietic Cell Transplantation: A Cohort Study

  2022cites this paper
• Engineering strategies to achieve efficient in vitro expansion of haematopoietic stem cells: development and improvement.

  2022cites this paper
• Airway disease in hematologic malignancies

  2022cites this paper
• Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey

  2022cites this paper
• Determining the symptoms and coping methods of patients at home after hematopoietic stem cell transplantation

  2022cites this paper
• Hematopoietic Stem-Cell Transplant Registry in Poland: 2020 Summaries.

  2022cites this paper
• Early intestinal microbial features are associated with CD4 T cell recovery after allogeneic hematopoietic transplant.

  2022cites this paper
• MSCs in Space: Mesenchymal Stromal Cell Therapeutics as Enabling Technology for Long-Distance Manned Space Travel

  2022cites this paper
• MSCs in Space: Mesenchymal Stromal Cell Therapeutics as Enabling Technology for Long-Distance Manned Space Travel

  2022cites this paper
• Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes.

  2022cites this paper
• The effect of pre-conditioning immunoglobulin and absolute lymphocyte count on the outcomes of allogeneic hematopoietic cell transplantation.

  2022cites this paper
• Evaluation of treosulfan cumulative exposure in paediatric patients through population pharmacokinetics and dosing simulations

  2022cites this paper
• Hematopoietic Stem Cell Transplantation Activity in China 2020–2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group

  2022cites this paper
• Evaluation of a group‐based exercise and relaxation rehabilitation program during hospitalization for allogeneic hematopoietic stem cell transplant

  2022cites this paper
• Pilot Trial of Homebound Hematopoietic Cell Transplantation.

  2022cites this paper
• Autologous hematopoietic stem cell transplantation in neuromyelitis optica spectrum disorder: A systematic review and meta-analysis

  2022cites this paper
• Gynecological complications in long-term survivors after allogeneic hematopoietic cell transplantation—a single-center real-life cross-sectional study

  2022cites this paper
• Efficacy and safety of a colostrum- and Aloe vera-based oral care protocol to prevent and treat severe oral mucositis in patients undergoing hematopoietic stem cell transplantation: a single-arm phase II study

  2022cites this paper
• Trends in disease indications for hematopoietic stem cell transplantation in the Asia-Pacific region: A report of the Activity Survey 2017 from APBMT

  2022cites this paper
• Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation

  2022cites this paper
• The contribution of the intestinal microbiome to immune recovery after HCT

  2022cites this paper
• Secure transplantation by tissue purging using photodynamic therapy to eradicate malignant cells.

  2022cites this paper
• Current status and prospects of hematopoietic stem cell transplantation in China

  2022cites this paper
• Nanoparticles targeting hematopoietic stem and progenitor cells: Multimodal carriers for the treatment of hematological diseases

  2022cites this paper
• Hypersensitivity reactions to liposomal amphotericin in a bone marrow transplant patient

  2022cites this paper
• Promising Stem Cell therapy in the Management of HIV and AIDS: A Narrative Review

  2022cites this paper